Understanding Vascular Complications in Aesthetic Medicine

Vascular complications are among the most serious adverse events in injectable aesthetic treatments. While rare, estimated at 1 in 6,000 to 1 in 20,000 filler injections, understanding them is important for informed treatment decisions and reinforces the critical importance of choosing a highly qualified practitioner.

What are vascular complications?

Vascular complications occur when dermal filler inadvertently enters, compresses, or obstructs a blood vessel, disrupting normal blood flow and potentially depriving downstream tissue of oxygen, a condition called ischaemia. Two primary mechanisms exist:

Intravascular injection: The needle tip enters a blood vessel and filler acts as an embolus blocking flow. Extravascular compression: Filler placed outside a vessel exerts sufficient pressure to compress it. Both can lead to tissue necrosis if untreated, and in extremely rare cases involving the ophthalmic artery system, vision loss.

High-risk areas

Certain facial areas carry higher risk due to vascular anatomy:

• Glabella: The supratrochlear and supraorbital arteries have potential connections to the ophthalmic artery.
• Nose: Complex vascular network with thin skin and tight tissue compartments.
• Nasolabial fold: The angular artery and facial artery run nearby.
• Tear trough: The infraorbital artery and orbital vasculature are in close proximity.
• Forehead and lips: Important arteries can be affected in these areas.

Vascular anatomy varies between individuals, making anatomical knowledge essential but not sufficient on its own.

Recognising warning signs

Early recognition is critical. Signs of arterial occlusion include immediate blanching (whitening of skin), disproportionate severe pain, dusky blue or purple discolouration, slow or absent capillary refill, and a net-like mottled pattern called livedo reticularis. Signs of vision compromise include blurring, visual field loss, flashing lights, eye pain, and pupil changes. Any of these require immediate emergency action.

Emergency management and risk reduction

The standard protocol involves stopping injection immediately, administering high-dose hyaluronidase (200-1,500 units), applying warm compresses and topical nitroglycerin, administering aspirin, and close monitoring. Repeat hyaluronidase doses may be needed. Visual symptoms require urgent ophthalmology referral.

Experienced practitioners reduce risk through detailed anatomical knowledge, aspiration before injecting, low injection pressure, small volume boluses, cannula use where appropriate, and emerging ultrasound guidance techniques. Every practitioner must carry hyaluronidase and know emergency protocols.

Frequently asked questions

How common are serious vascular complications?

Vascular occlusion occurs in approximately 1 in 6,000 to 1 in 20,000 injections. Vision-related complications are rarer still, with fewer than 200 cases reported globally. However, severity means every injection must be treated with appropriate vigilance.

Can vascular complications happen with any filler?

Yes, but HA fillers have a crucial advantage: they can be dissolved with hyaluronidase. This allows obstruction removal. Non-HA fillers cannot be dissolved, making complications more difficult to manage. This reversibility is why many practitioners prefer HA fillers in higher-risk areas.

What should I do if I notice warning signs?

Contact your treating practitioner immediately. If unreachable and experiencing severe symptoms, present to an emergency department. Time is critical for outcomes. Reputable clinics provide emergency contact details to all patients.

Does this mean fillers are dangerous?

Dermal fillers have an excellent overall safety profile with qualified practitioners. The key is choosing someone with comprehensive anatomical training, evidence-based techniques, emergency supplies, and complication management capability. Book a consultation with a clinical team, your safety is always our first priority.

This article is for educational purposes and does not constitute medical advice. If you experience concerning symptoms after injectable treatment, seek immediate medical attention.